All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q3 report for JAZZ PHARMACEUTICALS, INC. on October 19, 2026, reporting $50,000 in lobbying income.

Lobbying for JAZZ PHARMACEUTICALS, INC. · Pharmaceutical company.

All filings by THE NICKLES GROUP, LLC · Everything JAZZ PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing. Issues related to orphan drugs.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem